Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eaton Vance Ohio Municipal Income Trust
(NQ:
EVO
)
3.880
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eaton Vance Ohio Municipal Income Trust
< Previous
1
2
3
4
5
6
7
8
Next >
7 Stable Stocks to Buy for 100% Returns by 2025
March 04, 2024
If you're looking for stability and the opportunity to double your returns by the time 2025 rolls around, check out these stable stocks.
Via
InvestorPlace
The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore.
February 15, 2024
Looking for the next generational winner in healthcare stocks? These are three of the top prospects today.
Via
InvestorPlace
Just - Evotec Biologics Expands Development and Manufacturing Agreement with ABL for Broadly Neutralising Antibodies Against HIV
February 06, 2024
Via
ACCESSWIRE
Evotec SE: Invitation to Conference Call
January 21, 2024
Via
ACCESSWIRE
What's Going On With Life Science Company Evotec Stock Today?
January 10, 2024
Evotec SE (NASDAQ: EVO) joined forces with the Crohn's & Colitis Foundation to advance drug discovery and identify novel therapies for inflammatory bowel disease (IBD).
Via
Benzinga
A Preview Of Evotec's Earnings
November 07, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About Evotec
August 31, 2023
Via
Benzinga
Evotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD Therapies
January 10, 2024
Via
ACCESSWIRE
Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb
January 07, 2024
Via
ACCESSWIRE
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 04, 2024
Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<
Via
Benzinga
Why Is Mobileye (MBLY) Stock Down 26% Today?
January 04, 2024
Mobileye stock is taking a beating on Thursday with investors in MBLY bemoaning the company's revenue outlook for the year.
Via
InvestorPlace
Can TikTok Save Peloton (PTON) Stock?
January 04, 2024
Peloton stock is heading higher on Thursday as investors in PTON react to the company signing a new partnership with TikTok.
Via
InvestorPlace
Why Is Evotec (EVO) Stock Down 12% Today?
January 04, 2024
Evotec stock is falling on Thursday with heavy trading of EVO shares following the resignation of the company's CEO, Dr. Werner Lanthaler.
Via
InvestorPlace
Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
January 04, 2024
Shares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results for its second quarter.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
January 04, 2024
Pre-market stock movers are a hot topic this morning as we cover all of the biggest market news traders need to know about on Thursday!
Via
InvestorPlace
Why Germany-Based Life Science Company Evotec Shares Are Falling Today
January 04, 2024
Evotec SE (NASDAQ: EVO) shares are trading lower
Via
Benzinga
Cal-Maine Posts Downbeat Q2 Results, Joins Dyne Therapeutics, OPKO Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
January 04, 2024
U.S. stock futures were higher this morning, with the Dow Jones futures gaining around 50 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Evotec and Owkin Enter an A.I.-Powered Strategic Partnership to Accelerate Therapeutics Pipeline in Oncology and I&I
January 03, 2024
Via
ACCESSWIRE
Evotec Announces CEO Transition
January 03, 2024
Via
ACCESSWIRE
Evotec receives US$ 2.5 M Grant to Leverage Human iPSC-Derived Teratogenicity Platform for Global Health Programmes
December 18, 2023
Via
ACCESSWIRE
Evotec Enters Partnership with Charité to Expand Molecular Patient Database in Autoimmune Diseases
December 14, 2023
Via
ACCESSWIRE
Evotec-partner Jingxin Receives Approval for EVT201 in China
December 06, 2023
Via
ACCESSWIRE
Evotec Presents Precision Medicine Platforms for Accelerated Pipeline Building at Capital Markets Day
November 15, 2023
Via
ACCESSWIRE
Evotec SE Reports Results for the First Nine Months 2023 and Provides Corporate Update
November 08, 2023
Via
ACCESSWIRE
Evotec and Dewpoint Therapeutics Enter Strategic Partnership in Oncology
November 07, 2023
Via
ACCESSWIRE
Evotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners launch '65LAB'
October 05, 2023
Via
ACCESSWIRE
Evotec SE: Launch of Partnering Agreement to Strengthen Biotech Innovators in Shared R&D Economy
September 27, 2023
Via
ACCESSWIRE
Evotec and Novo Nordisk Launch LAB eN² to Accelerate Translation in Cardiometabolic Diseases
September 26, 2023
Via
ACCESSWIRE
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
September 21, 2023
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday.
Via
Benzinga
Salesforce To Rally Around 25%? Here Are 10 Other Analyst Forecasts For Thursday
August 31, 2023
Needham raised the price target for CrowdStrike Holdings, Inc. (NASDAQ: CRWD) from $170 to $200. Needham analyst Alex Henderson maintained a Buy rating. CrowdStrike shares rose 1.7% to close at $149.18...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.